Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 18, 2009 - Issue 10
Submit an article Journal homepage
221
Views
12
CrossRef citations to date
0
Altmetric
Reviews

Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?

Fausto Petrelli Treviglio Hospital, Oncology Unit, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy +39 0363424420; +39 0363424380; [email protected]
,
Mary Cabiddu Treviglio Hospital, Oncology Unit, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy +39 0363424420; +39 0363424380; [email protected]
,
Mara Ghilardi Treviglio Hospital, Oncology Unit, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy +39 0363424420; +39 0363424380; [email protected]
&
Sandro Barni Treviglio Hospital, Oncology Unit, Piazzale Ospedale 1, 24047 Treviglio (BG), Italy +39 0363424420; +39 0363424380; [email protected]
Pages 1467-1477 | Published online: 08 Sep 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Otávio Clark, Tobias Engel Ayer Botrel, Luciano Paladini & Mariana Bhering Andrade Ferreira. (2014) Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis. Core Evidence 9, pages 1-11.
Read now

Articles from other publishers (11)

Soley Bayraktar & Banu K. Arun. 2019. Breast Disease. Breast Disease 39 61 .
Rainer Girgert, G�nter Emons & Carsten Gr�ndker. (2016) 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib. Oncology Reports.
Crossref
Soley Bayraktar & Banu K. Arun. 2016. Breast Disease. Breast Disease 57 87 .
Dimitrios Panousis, P. Ntasiou, D. Grosomanidis, K. Chatzopoulos, E. Lagoudianakis, E. Charitidou & G. Xepapadakis. (2014) Single centre clinical study of a Greek patient population with triple-negative breast cancer. Hellenic Journal of Surgery 86:5, pages 280-286.
Crossref
Roxana Chiorean, Cornelia Braicu & Ioana Berindan-Neagoe. (2013) Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?. The Breast 22:6, pages 1026-1033.
Crossref
Kevin P. Williams, Jennifer L. Allensworth, Shalonda M. Ingram, Ginger R. Smith, Amy J. Aldrich, Jonathan Z. Sexton & Gayathri R. Devi. (2013) Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization. Cancer Letters 337:1, pages 77-89.
Crossref
Soley BayraktarStefan Glück. (2012) Management of women with BRCA1 / 2 mutation-associated breast cancer . Breast Cancer Management 1:2, pages 157-164.
Crossref
Chandra Bartholomeusz, Ana M. Gonzalez-Angulo, Ping LiuNaoki Hayashi, Ana Lluch, Jaime Ferrer-Lozano & Gabriel N. Hortobágyi. (2012) High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients. The Oncologist 17:6, pages 766-774.
Crossref
. (2011) Current World Literature. Current Opinion in Obstetrics & Gynecology 23:1, pages 58-63.
Crossref
Xinhui Wang, Takuya Osada, Yangyang Wang, Ling Yu, Koichi Sakakura, Akihiro Katayama, James B. McCarthy, Adam Brufsky, Mamatha Chivukula, Thaer Khoury, David S. Hsu, William T. Barry, H. Kim Lyerly, Timothy M. Clay & Soldano Ferrone. (2010) CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer. JNCI: Journal of the National Cancer Institute 102:19, pages 1496-1512.
Crossref
Ji Yeon KimTaeeun KimEun Yoon Cho. (2010) Comparative Study of Metaplastic Breast Carcinoma and Triple-Negative Breast Carcinoma Using Histologic and Immunohistochemical Analyses. The Korean Journal of Pathology 44:6, pages 605.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.